Quality of life and performance status after whipples surgery: experience from Sheikh Russel National Gastroliver Institute and Hospital

Asma Sultana; S. M. Mortaza Ahsan; Mohammad M. Alam; Beethi Sarkar; Sanjit K. Banik; Rasel Mahmud; Manmunur Rahman

doi:10.18203/2349-2902.isj20242112

Authors

Asma Sultana Department of Surgical Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh
S. M. Mortaza Ahsan Department of Surgical Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh
Mohammad M. Alam Department of Surgical Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh
Beethi Sarkar Department of Surgical Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh
Sanjit K. Banik Department of Surgical Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh
Rasel Mahmud Department of Surgical Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh
Manmunur Rahman Department of Surgical Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2349-2902.isj20242112

Keywords:

Pancreatic cancer, Pancreaticoduodenectomy, Quality of life, Whipple

Abstract

Background: Whipple surgery, or pancreaticoduodenectomy, is a complex surgical procedure often performed to treat pancreatic and periampullary cancers. Quality of life (QOL) and performance status are critical metrics for assessing post-operative outcomes. This study aimed to evaluate the QOL and performance status of patients after Whipple surgery in a tertiary care centre in Bangladesh.

Methods: This cross-sectional study was conducted among 64 patients who underwent Whipple surgery at the Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh between January 2021, and January 2023. The World Health Organization Quality of Life-BREF (WHOQOL-BREF) and Eastern Cooperative Oncology Group (ECOG) performance scales were used to assess QOL and performance status, respectively. Data were analyzed using descriptive and inferential statistics.

Results: Most participants were aged between 43 and 53 years, with a mean age of 54.66 years, and were predominantly male (64.06%). Most participants rated their physical health (34.37%) and psychological state (37.50%) as "good." Most patients (57.81%) experienced uneventful post-operative recovery. About (34.37%) was "restricted in strenuous work." Chemotherapy negatively impacted physical health (r=-0.198, p=0.02).

Conclusions: The findings indicate that most patients experienced favourable outcomes in both QOL and performance status following Whipple surgery. The results underscore the importance of holistic patient care and highlight potential areas for clinical improvement and future research.

Metrics

Metrics Loading ...

References

Huang J, Lok V, Ngai C, Zhang L, Yuan J, Lao X, et al. Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer. Gastroenterology. 2024;6.

Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10–27.

Kan C, Liu N, Zhang K, Wu D, Liang Y, Cai W, et al. Global, Regional, and National Burden of Pancreatic Cancer, 1990– 2019: Results from the Global Burden of Disease Study 2019. Ann Glob Health. 2019;89(1):33.

Tolou-Ghamari Z. Pancreatic cancer: Demographics and prevalence. Clin Cancer Investig J. 2020;9(4):155.

Sung JP, Stewart RD, O’Hara VS, Westhpal KF, Wilkinson JE, Hill J. A study of forty-nine consecutive whipple resections for periampullary adenocarcinoma. The American Journal of Surgery. 1997;174(1):6–10.

Udhayachandhar R, Otokwala J, Korula P, Rymbai ML, Chandy T, Joseph P. Perioperative factors impacting intensive care outcomes following Whipple procedure: A retrospective study. Indian J Anaesth. 2020;64:216–21.

Crist DW, Sitzmann JV, Cameron JL. Improved Hospital Morbidity, Mortality, and Survival after the Whipple Procedure. Ann Surg. 1987;206(3):358.

Witzigmann H, Max D, Uhlmann D, Geiβler F, Ludwig S, Schwarz R, et al. Quality of life in chronic pancreatitis: A prospective trial comparing classical whipple procedure and duodenum-preserving pancreatic head resection. JOGS. 2002;6:173–80.

Hildebrand P, Duderstadt S, Jungbluth T, Roblick U, Bruch H, Czymek R. Evaluation of the quality of life after surgical treatment of chronic pancreatitis. JOP : Journal of the pancreas. 2011;12 4:364–71.

Shaw K, Thomas AS, Rosario V, Kwon W, Schrope B, Sugahara K, et al. Long term quality of life amongst pancreatectomy patients with diabetes mellitus. Pancreatology: official journal of the IAP. 2024;6

Cawich S, Thomas DAW, Pearce N, Naraynsingh V. Whipple’s pancreaticoduodenectomy at a resource-poor, low-volume center in Trinidad and Tobago. World Journal of Clinical Oncology. 2022;13:738–47.

Sehgal K, Gill RR, Widick P, Bindal P, McDonald DC, Shea M, et al. Association of Performance Status With Survival in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy. JAMA Network Open. 2024;21:4(2).

Emekli E, Gündoğdu E. Computed tomography evaluation of early post-operative complications of the Whipple procedure. Polish Journal of Radiology. 2020;85:104–9.

McLeod R, Taylor B, O’Connor B, Greenberg G, Jeejeebhoy K, Royall D, et al. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. American journal of surgery. 1995;169 1:179–85.

Li SZ, Zhen TT, Wu Y, Wang M, Qin TT, Zhang H, et al. Quality of life after pancreatic surgery. World J Gastroenterol. 2024 Feb 28;30(8):943–55.

Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman J, et al. Quality of Life and Outcomes After Pancreaticoduodenectomy. Ann Surg. 2000 Jun;231(6):890–8.

Kozuschek W, Reith H, Waleczek H, Haarmann W, Edelmann M, Sonntag D. A comparison of long term results of the standard Whipple procedure and the pylorus preserving pancreatoduodenectomy. Journal of the American College of Surgeons. 1994;178 5:443–53.

Roick J, Danker H, Kersting A, Dietrich A, Dietz A, Papsdorf K, et al. The association of socioeconomic status with quality of life in cancer patients over a 6-month period using individual growth models. Supportive Care in Cancer. 2019;1–9.

Wilailak S, Lertkhachonsuk A, Lohacharoenvanich N, Luengsukcharoen S, Jirajaras M, Likitanasombat P, et al. Quality of life in gynecologic cancer survivors compared to healthy check-up women. J Gynecol Oncol. 2011;22:103–9.

Bergman B, Sullivan M, Sörenson S. Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile. Acta Oncologica. 1992;31:19–28.

Ahmed S, Khalil S. Relationship between health-related quality of life and self-esteem of adult patients receiving chemotherapy for cancer treatment. International Journal of Advanced Nursing Studies. 2017;6:63–6.

Short PF, Mallonee E. Income Disparities in the Quality of Life of Cancer Survivors. Medical Care. 2006;44:16–23.

Changazi SH, Ahmed QA, Bhatti S, Siddique S, Raffay EA, Farooka MW, et al. Whipple Procedure: A Five-Year Clinical Experience in Tertiary Care Center. Cureus. 2024;6:12.

Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM. A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1988 Dec;11(6):630–3.

Ford J, Hanna M, Boston A, Berri R. Life after hyperthermic intraperitoneal chemotherapy; measuring quality of life and performance status after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. American journal of surgery. 2016;211 3:546–50.

Shoulah AS, Saleh MA, Abdelwahab S, Elawady MA, Elsheikh E. Evaluation of health related quality of life in cancer patients receiving chemotherapy. Science Journal of Public Health.2024;5.

Eichler M, Singer S, Janni W, Harbeck N, Rack B, Augustin D, et al. Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial. Breast Cancer. 2016;24:319–25.

Klein J, Lüdecke D, Hofreuter-Gätgens K, Fisch M, Graefen M, Knesebeck O von dem. Income and health-related quality of life among prostate cancer patients over a one-year period after radical prostatectomy: a linear mixed model analysis. Quality of Life Research. 2017;26:2363–73.